*Special Treat Da Yao issued a notice of abnormal stock trading. The company's net income before and after deducting non-recurring gains and losses audited in 2023 were negative, and the business revenue unrelated to the main business and the revenue without commercial substance after deduction was less than 100 million yuan and has been subject to delisting risk warning. If any of the provisions of Article 9.3.12 of the revised Shanghai Stock Exchange Listing Rules (April 2024) occur in the company's fiscal year 2024, the company's stocks will be decided by the Shanghai Stock Exchange to be terminated from listing.
*ST大药：公司股票可能存在被终止上市的风险
*Special Treat Da Yao: There may be a risk of the company's stocks being delisted.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.